Who Exports Burnol from India — 32 Suppliers Behind a $64.9K Market

Hyderabad, often referred to as the "Bulk Drug Capital of India," is a pivotal hub for pharmaceutical manufacturing, particularly in active pharmaceutical ingredients (APIs). The city hosts Genome Valley, India's first biotech cluster, and is home to over 800 pharmaceutical companies, including major players like Dr. Reddy’s Laboratories and Aurobindo Pharma. The region's advanced R&D infrastructure and skilled workforce make it a strategic location for API production, which is essential for formulations like Burnol.

The Ahmedabad-Vadodara corridor in Gujarat is renowned for its robust pharmaceutical industry, contributing nearly 28% of India's pharma production. This region is home to leading companies such as Zydus Lifesciences and Cadila Pharmaceuticals, specializing in the production of generic drugs and formulations. The well-established infrastructure and regulatory compliance in this area make it a favorable environment for manufacturing topical formulations like Burnol.

The Mumbai-Thane-Raigad belt serves as a significant export gateway for pharmaceutical products due to its strategic coastal location and proximity to major ports. This region hosts numerous pharmaceutical companies and offers well-developed logistics and distribution networks, facilitating efficient export operations. For products like Burnol, leveraging this cluster can enhance access to international markets.

Baddi-Nalagarh in Himachal Pradesh has emerged as a prominent pharmaceutical manufacturing hub, housing over 1,000 pharma companies. The region's growth was significantly driven by tax incentives and government support, attracting major players like Morepen Laboratories, the manufacturer of Burnol. Baddi's infrastructure and skilled workforce make it a strategic location for pharmaceutical production.

• Diversify Supplier Base: Given that the top five exporters account for 35.3% of Burnol exports, expanding the supplier network can mitigate risks associated with over-reliance on a few exporters.

• Leverage Established Clusters: Utilize the manufacturing capabilities of established pharmaceutical hubs like Hyderabad and Ahmedabad-Vadodara to ensure consistent quality and supply of Burnol.

• Optimize Export Logistics: Capitalize on the Mumbai-Thane-Raigad region's export infrastructure to streamline international distribution and reduce lead times.

• Monitor Regulatory Compliance: Ensure that all manufacturing partners adhere to the regulatory standards set by authorities such as the CDSCO and DGFT to maintain product quality and compliance.